CLOSE

Specials

  • March
  • June
  • September
  • Bioanalytical Services
  • Life Science Analytics
  • Life Science Compliance
  • Bioanalytical Services APAC
  • APAC
  • Europe

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Life Sciences: Potential Compliance Implications

Life Sciences: Potential Compliance...

Major Risk Considerations for Life Sciences Industry

Major Risk Considerations for Life...

The Role of Automation in Pharma Regulatory

The Role of Automation in Pharma...

Enhancing Quality Management Objectives with Quality 4.0

Enhancing Quality Management...

How Life Sciences Firms Can Improve Regulatory Compliance

How Life Sciences Firms Can Improve...

Navigating Life Sciences Compliance Landscape in the Era of Pandemic

Navigating Life Sciences Compliance...

Life Sciences: How Businesses Can Position Themselves for Success with AI

Life Sciences: How Businesses Can...

How Cloud Can Help in Life Science Quality Management

How Cloud Can Help in Life Science...

Life Sciences: Potential Compliance Implications

Life Sciences: Potential Compliance...

Major Risk Considerations for Life Sciences Industry

Major Risk Considerations for Life...

The Role of Automation in Pharma Regulatory

The Role of Automation in Pharma...

Enhancing Quality Management Objectives with Quality 4.0

Enhancing Quality Management...

How Life Sciences Firms Can Improve Regulatory Compliance

How Life Sciences Firms Can Improve...

Navigating Life Sciences Compliance Landscape in the Era of Pandemic

Navigating Life Sciences Compliance...

Life Sciences: How Businesses Can Position Themselves for Success with AI

Life Sciences: How Businesses Can...

How Cloud Can Help in Life Science Quality Management

How Cloud Can Help in Life Science...

Compliance in the Life Sciences Sector

By Life Sciences Review | Wednesday, February 03, 2021
Tweet

It will benefit the life science compliance team if they collaborate with trusted partners to reduce risk. 


FREMONT, CA: There are several issues specific to the field because any compliance professional employed in life sciences recognizes them. It is a highly regulated industry, and compliance programs in the life sciences often become complicated, involving multiple jurisdictions addressing extended supply chains and numerous third parties. Life sciences compliance has been put under scrutiny to look at challenges presently the industry is dealing with, how to solve them, and what is there in the future.


Unavoidable Compliance Risks


When it comes to bribery and corruption, the life sciences industry does not have a decent reputation. It is estimated that more than US$7 trillion is spent on health care worldwide, according to The Lancet, but at least 10-25 percent of this global investment is wasted directly through corruption.


The stakeholders' structure is a primary explanation for this, with many companies directly partnering with hospitals or other government-owned entities. Strong dependency on sales teams and third-party agents or finders to attract government customers reveals an apparent vulnerability to public corruption. As a result, businesses, powered by local customs and regulations, are subject to many enforcement problems, which may include:


• Management of gifts and entertainment


• Exposure to government interference


• A common use of kickbacks in the sales process


• Engagement with politically exposed persons


• Complex supply chains


See Also: Top Pharma and Life Sciences Analytics Consulting Companies


Many compliance programs for life sciences are costly and unwieldy. Some work in silos or are isolated, missing an enterprise-wide view of the problems they face in compliance. In addition to this tension between the management of regulatory risk and the achievement of business objectives, it is obvious why issues occur.


Rising to the Challenge: Next-Gen Compliance


To prevent a regulatory fall-out, it is essential for life sciences companies build a comprehensive enforcement strategy enterprise-wide. In enabling this to happen, the enhancement of enforcement and risk management systems through the implementation of technology frameworks would play a key role. Compliance anomalies would be easier to detect and fix as compliance procedures become more automated.


For example, using a compliance platform for third-party management that continuously reviews each third-party relationship's status would detect problems before they trigger concern. By integrating upfront and annual enforcement training for both workers and third parties, such a platform could serve a dual purpose. In a post-merger situation, introducing AI-based technologies to support high volume diligence remediation services may also help define FCPA's successor responsibility in inherited transactions.


Compliance teams in the life sciences will benefit from partnering to support successful risk reduction initiatives with a trusted partner. They have extensive experience at IntegrityRisk, helping clients manage a broad range of risks to produce positive results.


Weekly Brief

loading
Towards a New World Order
> <
  • Other 2021

    Top Vendors

    Current Issue
  • Other 2020

    Top Vendors

    Current Issue

Read Also

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Importance of Biomarkers in Drug Development

Importance of Biomarkers in Drug Development

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects of Immunotherapy

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care
The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech Sector

Why Partner with Bioanalysis Experts?

Why Partner with Bioanalysis Experts?

Cyberattacks in Hospitals

Cyberattacks in Hospitals

Principles of Sustainability in Pharmaceutical Packaging

Principles of Sustainability in Pharmaceutical Packaging
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/compliance-in-the-life-sciences-sector-nwid-245.html